Dr Adnan Hussain, MD | |
99 Beauvoir Ave, Summit, NJ 07901-3533 | |
(908) 522-2000 | |
Not Available |
Full Name | Dr Adnan Hussain |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 24 Years |
Location | 99 Beauvoir Ave, Summit, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215297429 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Overlook Medical Center | Summit, NJ | Hospital |
Morristown Medical Center | Morristown, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
In studying the postmortem brain tissue of adults who had been diagnosed with schizophrenia, the researchers found that levels of certain gene-regulating molecules called microRNAs were lower among schizophrenia patients than in persons who were free of psychiatric illness.
The biggest surprise to me was that we could rescue the autistic phenotype [in the human cells] to something close to normal, said Alysson Muotri of the University of California San Diego.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
Researchers have found promising results for treating depression with a video game interface that targets underlying cognitive issues associated with depression rather than just managing the symptoms.
› Verified 6 days ago
Entity Name | Practice Associates Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
In studying the postmortem brain tissue of adults who had been diagnosed with schizophrenia, the researchers found that levels of certain gene-regulating molecules called microRNAs were lower among schizophrenia patients than in persons who were free of psychiatric illness.
The biggest surprise to me was that we could rescue the autistic phenotype [in the human cells] to something close to normal, said Alysson Muotri of the University of California San Diego.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
Researchers have found promising results for treating depression with a video game interface that targets underlying cognitive issues associated with depression rather than just managing the symptoms.
› Verified 6 days ago
Entity Name | Jersey Intensivist Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255776951 PECOS PAC ID: 3971746470 Enrollment ID: O20130903000343 |
News Archive
In studying the postmortem brain tissue of adults who had been diagnosed with schizophrenia, the researchers found that levels of certain gene-regulating molecules called microRNAs were lower among schizophrenia patients than in persons who were free of psychiatric illness.
The biggest surprise to me was that we could rescue the autistic phenotype [in the human cells] to something close to normal, said Alysson Muotri of the University of California San Diego.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
Researchers have found promising results for treating depression with a video game interface that targets underlying cognitive issues associated with depression rather than just managing the symptoms.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Adnan Hussain, MD 1 Springfield Ave, Summit, NJ 07901-4055 Ph: (908) 934-0555 | Dr Adnan Hussain, MD 99 Beauvoir Ave, Summit, NJ 07901-3533 Ph: (908) 522-2000 |
News Archive
In studying the postmortem brain tissue of adults who had been diagnosed with schizophrenia, the researchers found that levels of certain gene-regulating molecules called microRNAs were lower among schizophrenia patients than in persons who were free of psychiatric illness.
The biggest surprise to me was that we could rescue the autistic phenotype [in the human cells] to something close to normal, said Alysson Muotri of the University of California San Diego.
PPD, Inc. today confirmed that Takeda Pharmaceutical Company Limited's new drug application for NESINA® (alogliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, was approved by the Japanese Ministry of Health, Labour and Welfare on April 16. PPD's compound partnering division collaborated with Takeda to develop this product.
Researchers have found promising results for treating depression with a video game interface that targets underlying cognitive issues associated with depression rather than just managing the symptoms.
› Verified 6 days ago
Manoj M Trivedi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 802 Old Springfield Ave, Summit, NJ 07901 Phone: 908-273-5644 Fax: 908-273-1435 | |
Dr. Olumuyiwa Adedotun Ibikunle, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Sona Khurana, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-6414 | |
Asma Jafri, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
David Jordanovski, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Andrew Toscano, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Springfield Ave, Summit, NJ 07901 Phone: 973-656-6280 | |
Nisha Suresh Kotecha, M.B.B.S. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Springfield Ave, Summit, NJ 07901 Phone: 908-934-0555 |